Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT03849586

Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction

Prospective collection of pre-defined parameters on the surgical treatment of male erectile dysfunction using Penile Prosthesis Implants (PPIs).

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

University Hospital Antwerp, Antwerp, Belgium

Loading trial locations.

About this study

This will be a prospective collection of pre-defined parameters on the surgical treatment of male erectile dysfunction using Penile Prosthesis Implants (PPIs). The data collection will be undertaken from multiple centres in Europe. The participation will be by open invitation from the European Association of Urology (EAU) Section of Genitourinary Reconstructive Surgeons (ESGURS) to all its members, along with other urologists undertaking these procedures.

There will be no restriction on the number of patients enrolled per centre as long as they are consecutive. The aim is to have a long term collection of the dataset from as many centres as possible. An initial assessment for the robustness of the data collection and first clinical evaluation of the data collected will be performed 1 and 2 years after recruitment of the first patient by a nominated steering committee. Thereafter, the evaluations will be performed every 2 years until the end of Registry (10 years after the first patient was enrolled).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male patient undergoing a surgical penile prosthesis implant for treatment of erectile dysfunction.
  • Participant is willing and able to give informed consent for participation in the Registry and is able to complete the questionnaires.

Exclusion criteria

  • Participating center is unable to contribute consecutive patients.

Treatment and study plan

Primary outcomes

  1. Patient Satisfaction score

    Time frame: at week 12, year 1, 2, 4, 6, 8 and 10 after surgery

    Patient Satisfaction score is defined as the mean patient satisfaction score as indicated by the Modified Patient EDITS Questionnaire. All items on the Patient EDITS will be scored from zero (no satisfaction or dissatisfaction) to four (high satisfaction). The mean satisfaction score for each patient will be calculated. To place scores in an easily interpretable metric, each mean score will be multiplied by 25 so that EDITS scores could range from a low of 0 (extremely low treatment satisfaction) to a high of 100 extremely high treatment satisfaction).

Secondary outcomes

  1. Partner Satisfaction score

    Time frame: at week 12, year 1, 2, 4, 6, 8 and 10 after surgery

    Partner Satisfaction score is defined as the mean partner satisfaction score as indicated by the Modified Partner EDITS Questionnaire. All items on the Partner EDITS will be scored from zero (no satisfaction or dissatisfaction) to four (high satisfaction). The mean satisfaction score for the partner will be calculated. To place scores in an easily interpretable metric, each mean score will be multiplied by 25 so that EDITS scores could range from a low of 0 (extremely low treatment satisfaction) to a high of 100 extremely high treatment satisfaction).

  2. Patient satisfaction rate

    Time frame: at week 12, year 1, 2, 4, 6, 8 and 10 after surgery

    The number of patients with an EDITS score ≥ 50 compared to the total number of patients

  3. Partner satisfaction rate

    Time frame: at week 12, year 1, 2, 4, 6, 8 and 10 after surgery

    The number of partners with an EDITS score ≥ 50 compared to the total number of partners

  4. Overall time being satisfied with treatment since implantation

    Time frame: up to 10 years post surgery

    The interval from the date of regaining a patient EDITS score of 50 or more until the time of EDITS score of less than 50

  5. International Index of Erectile Function - 5 (IIEF short form/SHIM) questionnaire

    Time frame: at baseline, week 12, year 1, 2, 4, 6, 8 and 10 after surgery

    The IIEF-5 score is the sum of the ordinal responses to five items; thus, the score can range from 0 to 25. Erectile Dysfunction (ED) severity can be classified into the following five categories based on IIEF-5 scores; severe (0-7), moderate (8-11), mild to moderate (12-16), mild (17-21), and no ED (22- 25). Mean IIEF-5 scores will be calculated at the indicated time points and numbers / percentages of patients in the different ED severity categories. Also change in IIEF-5 score compared to baseline will be calculated.

  6. Sexual Encounter Profile (SEP) questions 2 and 3

    Time frame: at baseline, week 12, year 1, 2, 4, 6, 8 and 10 after surgery

    For SEP question 2 and 3, scores are percentage of yes responses relative to number of sexual attempts/encounters. Proportions of yes responses will be treated as continuous variables. Post-operative results will also be compared to baseline.

  7. EQ-5D-5L quality of life questionnaire

    Time frame: at baseline, week 12, year 1, 2, 4, 6, 8 and 10 after surgery

    Results of the EQ-5D-5L quality of life questionnaire will be analyzed as described in the EuroQol EQ-5D-5L user guide. Post-operative results will also be compared to baseline.

  8. Quality of Life and Sexuality with Penile Prosthesis (QoLSPP) questionnaire

    Time frame: at week 12, year 1, 2, 4, 6, 8 and 10 after surgery

    QoLSPP is a 16-item questionnaire, with 4 domains: the functional, relational, social and personal domain. Responses are structured according to a six-point Likert scale, in most cases ranging from "never" (0) to "always" (5), where higher values represent more positive responses. Individual item scores will be analyzed as well as domain scores.

  9. Complications

    Time frame: during surgery and up to 10 years after surgery

    Type of complications, associated symptoms and whether or not a revision was needed will be recorded.

  10. Immediate Postoperative complications

    Time frame: until 2 weeks after surgery

    Type of complications, associated symptoms and whether or not a revision was needed will be recorded and classified according to the Clavien Dindo grading system.

  11. Time of first activation, first cycling, first use, first intercourse, first orgasm, if applicable

    Time frame: up to 10 years post surgery

    The date of first cycling (inflating and deflating the prosthesis several times), the date of first activation and first use for sexual activity, the date of first sexual intercourse and the date of first orgasm, if applicable, will be reported.

  12. Time being revision-free

    Time frame: up to 10 years post surgery

    The interval from the date of surgery to the date of revision whereby revision is defined as any urogenital surgical intervention that is related to the function, placement, or site reaction to the implanted device

  13. Revision-free rate

    Time frame: at 1, 2, 4, 6, 8 and 10 years of Registry follow-up

    The number of patients who are revision-free compared to the total number of patients.

Sponsors and collaborators

Lead sponsor

European Association of Urology Research Foundation

Other

Collaborators

  • Boston Scientific Corporation
  • Coloplast A/S

Registry information

Official study title

Prospective Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction

Acronym: PHOENIX

Important dates

Study start
2021
Primary completion
2032
Study completion
2032
First posted
Feb 21, 2019
Registry last updated
Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.